CVS HEALTH CORP (CVS) Forecast, Price Target & Analyst Ratings

NYSE:CVS • US1266501006

Current stock price

73.02 USD
-1.79 (-2.39%)
At close:
73.13 USD
+0.11 (+0.15%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CVS HEALTH CORP (CVS).

Forecast Snapshot

Consensus Price Target

Price Target
$95.74
+ 31.11% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$2.26
Revenue Estimate
96.459B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
79.39%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$95.74
Upside
+ 31.11%
From current price of $73.02 to mean target of $95.74, Based on 33 analyst forecasts
Low
$79.79
Median
$96.90
High
$110.25

Price Target Revisions

1 Month
0.08%
3 Months
3.53%

Price Target Summary

33 Wall Street analysts provided a forecast for the next 12 months for CVS. The average price target is 95.74 USD. This implies a price increase of 31.11% is expected in the next year compared to the current price of 73.02.
The average price target has been revised upward by 3.53% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CVS Current Analyst RatingCVS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

CVS Historical Analyst RatingsCVS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
79.39%
CVS was analyzed by 33 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about CVS.
In the previous month the buy percentage consensus was at a similar level.
CVS was analyzed by 33 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-12BernsteinUpgrade Market Perform -> Outperform
2026-01-28Argus ResearchMaintains Buy -> Buy
2026-01-27B of A SecuritiesMaintains Buy -> Buy
2025-12-17JP MorganMaintains Overweight -> Overweight
2025-12-12BernsteinMaintains Market Perform -> Market Perform
2025-12-10MizuhoMaintains Outperform -> Outperform
2025-12-10UBSMaintains Buy -> Buy
2025-12-10BarclaysMaintains Overweight -> Overweight
2025-12-10Truist SecuritiesMaintains Buy -> Buy
2025-12-10BairdMaintains Outperform -> Outperform
2025-12-10Morgan StanleyMaintains Overweight -> Overweight
2025-12-10Piper SandlerReiterate Overweight -> Overweight
2025-12-05BernsteinMaintains Market Perform -> Market Perform
2025-11-13Wells FargoMaintains Overweight -> Overweight
2025-11-03TD CowenMaintains Buy -> Buy
2025-10-30Cantor FitzgeraldMaintains Overweight -> Overweight
2025-10-30RBC CapitalMaintains Outperform -> Outperform
2025-10-30Evercore ISI GroupMaintains Outperform -> Outperform
2025-10-30Truist SecuritiesReiterate Buy -> Buy
2025-10-24UBSMaintains Buy -> Buy
2025-10-14Goldman SachsInitiate Buy
2025-10-14Morgan StanleyMaintains Overweight -> Overweight
2025-10-09MizuhoMaintains Outperform -> Outperform
2025-10-07Wells FargoMaintains Overweight -> Overweight
2025-09-05BernsteinMaintains Market Perform -> Market Perform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$2.26
Revenue Estimate
96.459B
Revenue Q2Q
1.98%
EPS Q2Q
0.49%
Number of Analysts
23

Next Earnings Revisions

Revenue (1 Month)
-1.61%
Revenue (3 Months)
-4.36%
EPS (1 Month)
-0.21%
EPS (3 Months)
-4.98%

Next Earnings Summary

CVS is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 2.26 USD and the consensus revenue estimate is 96.46B USD.
The next earnings revenue estimate has been revised downward by 4.36% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CVS revenue by date.CVS revenue by date.
357.776B
10.95%		372.809B
4.20%		402.067B
7.85%		409.619B
1.88%		428.306B
4.56%		448.873B
4.80%		473.107B
5.40%		493.393B
4.29%		514.995B
4.38%		547.437B
6.30%		581.527B
6.23%
EBITDA
YoY % growth
CVS ebitda by date.CVS ebitda by date.
N/A
0.50%		N/A
-27.63%		N/A
15.92%		18.005B
5.29%		19.98B
10.97%		22.141B
10.82%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
CVS ebit by date.CVS ebit by date.
15.086B
-7.39%		10.038B
-33.46%		10.502B
4.62%		15.437B
46.99%		17.195B
11.39%		19.105B
11.11%		21.079B
10.33%		22.701B
7.69%		N/AN/AN/A
Operating Margin
CVS operating margin by date.CVS operating margin by date.
4.22%2.69%2.61%3.77%4.01%4.26%4.46%4.60%N/AN/AN/A
EPS
YoY % growth
CVS eps by date.CVS eps by date.
8.74
0.46%		5.42
-37.99%		6.75
24.54%		7.25
7.45%		8.27
14.02%		9.60
16.14%		10.39
8.16%		11.31
8.91%		12.30
8.73%		13.61
10.67%		15.18
11.50%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		2.26
0.49%		1.84
1.61%		1.76
10.20%		1.30
19.59%		2.61
15.44%		2.20
19.88%		1.93
9.31%		1.51
15.47%
Revenue
Q2Q % growth		96.459B
1.98%		100.841B
1.95%		106.413B
3.44%		107.58B
1.79%		104.572B
8.41%		109.622B
8.71%		114.024B
7.15%		114.595B
6.52%
EBITDA
Q2Q % growth		5.163B
19.27%		4.532B
16.53%		4.415B
15.55%		3.506B
12.08%		5.991B
16.04%		5.188B
14.47%		4.507B
2.08%		4.086B
16.54%
EBIT
Q2Q % growth		4.628B
37.17%		3.925B
64.85%		3.826B
51.95%		2.886B
36.65%		5.235B
13.12%		4.579B
16.66%		4.017B
4.99%		3.276B
13.51%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CVS Yearly Revenue VS EstimatesCVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
CVS Yearly EPS VS EstimatesCVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.48%
EPS Next 5 Year
10.88%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
3.58%
Revenue Next 5 Year
4.08%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
15.26%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CVS HEALTH CORP / CVS Forecast FAQ

Can you provide the average price target for CVS HEALTH CORP stock?

33 analysts have analysed CVS and the average price target is 95.74 USD. This implies a price increase of 31.11% is expected in the next year compared to the current price of 73.02.

When does CVS HEALTH CORP (CVS) report earnings?

CVS HEALTH CORP (CVS) will report earnings on 2026-04-29, before the market open.

What are the consensus estimates for CVS stock next earnings?

The consensus EPS estimate for the next earnings of CVS HEALTH CORP (CVS) is 2.26 USD and the consensus revenue estimate is 96.46B USD.

How many analysts have analysed CVS HEALTH CORP (CVS)?

The number of analysts covering CVS HEALTH CORP (CVS) is 33.